{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T22:21:21Z","timestamp":1794522081100,"version":"4.9.1"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"vor","delay-in-days":730,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Surgery"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.ijsu.2017.01.115","type":"journal-article","created":{"date-parts":[[2017,2,2]],"date-time":"2017-02-02T19:03:52Z","timestamp":1486062232000},"page":"169-175","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":56,"special_numbering":"C","title":["The Charlson age comorbidity index predicts prognosis in patients with resected pancreatic cancer"],"prefix":"10.1097","volume":"39","author":[{"given":"Tomonari","family":"Asano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suguru","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsutomu","family":"Fujii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norimitsu","family":"Yabusaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Goro","family":"Nakayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Sugimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiko","family":"Koike","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michitaka","family":"Fujiwara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Kodera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"10.1016\/j.ijsu.2017.01.115_bib1","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1002\/cncr.10831","article-title":"Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? A phase III multicenter prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma","volume":"95","author":"Takada","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.ijsu.2017.01.115_bib2","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/sj.bjc.6605256","article-title":"A\u00a0randomised Phase III trial comparing Gemcitabine with surgery-only in patients with resected pancreatic cancer: Japanese Study Group of adjuvant therapy for pancreatic cancer","volume":"101","author":"Ueno","year":"2009","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ijsu.2017.01.115_bib3","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1001\/jama.2013.279201","article-title":"Adjuvant chemotherapy with gemcitabine and Long-term outcomes among patients with resected pancreatic cancer: the CONKO-001 randomized trial","volume":"310","author":"Oettle","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.ijsu.2017.01.115_bib4","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/j.gassur.2006.08.018","article-title":"1423Pancreaticoduodenectomies for pancreatic cancer: a single-institution experience","volume":"1423","author":"Winter","year":"2006","journal-title":"J.\u00a0Gastrointest. Surg."},{"key":"10.1016\/j.ijsu.2017.01.115_bib5","first-page":"CD002093","article-title":"Chemotherapy and radiotherapy for inoperable advanced pancreatic cancer","author":"Yip","year":"2006","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.ijsu.2017.01.115_bib6","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1177\/1758834014564775","article-title":"Advanced pancreatic adenocarcinoma: a review of current treatment strategies and developing therapies","volume":"7","author":"Teague","year":"2015","journal-title":"Ther. Adv. Med. Oncol."},{"key":"10.1016\/j.ijsu.2017.01.115_bib7","first-page":"881","article-title":"The Charlson Age comorbidity index predicts early mortality after surgery for pancreatic cancer","volume":"12","author":"Dias-Santos","year":"2014","journal-title":"Surgery"},{"key":"10.1016\/j.ijsu.2017.01.115_bib8","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.gassur.2004.09.045","article-title":"Evaluation of Charlson-Age comorbidity index as predictor of morbidity and mortality in patients with colorectal carcinoma","volume":"8","author":"Ouellette","year":"2004","journal-title":"J.\u00a0Gastrointest. Surg."},{"key":"10.1016\/j.ijsu.2017.01.115_bib9","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/S0895-4356(96)00271-5","article-title":"Practical considerations on the use of the Charlson comorbidity index with administrative data bases","volume":"49","author":"D'Hoore","year":"1996","journal-title":"J.\u00a0Clin. Epidemiol."},{"key":"10.1016\/j.ijsu.2017.01.115_bib10","doi-asserted-by":"crossref","first-page":"4196","DOI":"10.1002\/cncr.28329","article-title":"Updated long-term outcomes and prognostic factors for patients with unresectable locally advanced pancreatic cancer treated with intraoperative radiotherapy at the Massachusetts General Hospital, 1978 to 2010","volume":"119","author":"Cai","year":"2013","journal-title":"Cancer"},{"key":"10.1016\/j.ijsu.2017.01.115_bib11","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.ejca.2014.01.005","article-title":"Influence of comorbidity, Age and performance status on treatment efficacy and safety of cetuximab plus irinotecan in irinotecan-refractory elderly patients with metastatic colorectal cancer","volume":"50","author":"Jehn","year":"2014","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.ijsu.2017.01.115_bib12","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.clon.2014.06.002","article-title":"Locally advanced pancreatic cancer: the role of definitive chemoradiotherapy","volume":"26","author":"Huguet","year":"2014","journal-title":"Clin. Oncol. R. Coll. Radiol."},{"key":"10.1016\/j.ijsu.2017.01.115_bib13","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1007\/s00432-016-2115-6","article-title":"Partial liver resection results in a significantly better Long-term survival than locally ablative procedures even in elderly patients","volume":"142","author":"Bauschke","year":"2016","journal-title":"J.\u00a0Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.ijsu.2017.01.115_bib14","first-page":"308","article-title":"The decision-making process for senior cancer patients: treatment allocation of older women with operable breast cancer in the UK","volume":"12","author":"Morgan","year":"2015","journal-title":"Cancer Biol. Med."},{"key":"10.1016\/j.ijsu.2017.01.115_bib15","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1038\/bjc.2013.541","article-title":"Does comorbidity interact with colorectal cancer to increase mortality? A Nationwide population-based cohort study","volume":"109","author":"Erichsen","year":"2013","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ijsu.2017.01.115_bib16","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S1470-2045(10)70237-0","article-title":"FOLFIRINOX: a New Standard treatment for advanced pancreatic cancer?","volume":"12","author":"Kim","year":"2011","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ijsu.2017.01.115_bib17","series-title":"Highlights from the \u201c2011 ASCO Annual Meeting\u201d. Chicago, IL, USA; June 3-7, 2011. JOP 12","first-page":"334","article-title":"Novel agents for the treatment of pancreatic adenocarcinoma","author":"Cheng","year":"2011"},{"key":"10.1016\/j.ijsu.2017.01.115_bib18","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A\u00a0New method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J.\u00a0Chronic Dis."},{"key":"10.1016\/j.ijsu.2017.01.115_bib19","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/SLA.0b013e3181b13ca2","article-title":"The clavien-Dindo classification of surgical complications: five-year experience","volume":"250","author":"Clavien","year":"2009","journal-title":"Ann. Surg."},{"key":"10.1016\/j.ijsu.2017.01.115_bib20","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.surg.2005.05.001","article-title":"Postoperative pancreatic fistula: an International Study Group (ISGPF) definition","volume":"138","author":"Bassi","year":"2005","journal-title":"Surgery"},{"key":"10.1016\/j.ijsu.2017.01.115_bib21","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1002\/bjs.9307","article-title":"Value of peritoneal cytology in potentially resectable pancreatic cancer","volume":"100","author":"Yamada","year":"2013","journal-title":"Br. J. Surg."},{"key":"10.1016\/j.ijsu.2017.01.115_bib22","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1007\/s00268-013-2039-0","article-title":"Extended lymphadenectomy in pancreatic cancer is crucial","volume":"37","author":"Fujii","year":"2013","journal-title":"World J. Surg."},{"key":"10.1016\/j.ijsu.2017.01.115_bib23","article-title":"Pancreatic stump closure after pancreatoduodenectomy in elderly patients: a retrospective clinical study","volume":"11","author":"Mauriello","year":"2016","journal-title":"Aging Clin. Exp. Res. Nov."},{"key":"10.1016\/j.ijsu.2017.01.115_bib24","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1007\/s00268-005-0438-6","article-title":"Indications and techniques of extended resection for pancreatic cancer","volume":"30","author":"Nakao","year":"2006","journal-title":"World J. Surg."},{"key":"10.1016\/j.ijsu.2017.01.115_bib25","series-title":"International Union against Cancer (UICC). TNM Classification of Malignant Tumors","year":"2010"},{"key":"10.1016\/j.ijsu.2017.01.115_bib26","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1245\/s10434-014-4280-7","article-title":"Postoperative serum albumin Level is a marker of incomplete adjuvant chemotherapy in patients with pancreatic ductal adenocarcinoma","volume":"22","author":"Matsumoto","year":"2015","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.ijsu.2017.01.115_bib27","doi-asserted-by":"crossref","first-page":"e0148076","DOI":"10.1371\/journal.pone.0148076","article-title":"Adjusted Age-adjusted Charlson comorbidity index score as a risk measure of perioperative mortality before cancer surgery","volume":"11","author":"Chang","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.ijsu.2017.01.115_bib28","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1001\/jama.2010.1275","article-title":"Adjuvant chemotherapy with fluorouracil plus folinic Acid vs gemcitabine following pancreatic cancer resection: a randomized controlled trial","volume":"304","author":"Neoptolemos","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.ijsu.2017.01.115_bib29","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1056\/NEJMoa032295","article-title":"A\u00a0randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer","volume":"350","author":"Neoptolemos","year":"2004","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ijsu.2017.01.115_bib30","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1001\/jama.297.3.267","article-title":"Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer","volume":"297","author":"Oettle","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.ijsu.2017.01.115_bib31","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/sj.bjc.6603627","article-title":"Failure to Complete adjuvant chemotherapy is associated with adverse survival in stage III Colon cancer patients","volume":"96","author":"Morris","year":"2007","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ijsu.2017.01.115_bib32","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1245\/s10434-012-2776-6","article-title":"Body weight loss after surgery is an independent risk factor for continuation of S-1 adjuvant chemotherapy for gastric cancer","volume":"20","author":"Aoyama","year":"2013","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.ijsu.2017.01.115_bib33","doi-asserted-by":"crossref","first-page":"3921","DOI":"10.1200\/JCO.2010.34.1552","article-title":"Completion of adjuvant chemotherapy and use of health services for older women with epithelial ovarian cancer","volume":"29","author":"Fairfield","year":"2011","journal-title":"J.\u00a0Clin. Oncol."}],"container-title":["International Journal of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743919117301206?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743919117301206?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,2,22]],"date-time":"2023-02-22T11:04:22Z","timestamp":1677063862000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1743919117301206"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":33,"alternative-id":["S1743919117301206"],"URL":"https:\/\/doi.org\/10.1016\/j.ijsu.2017.01.115","relation":{},"ISSN":["1743-9191"],"issn-type":[{"value":"1743-9191","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Charlson age comorbidity index predicts prognosis in patients with resected pancreatic cancer","name":"articletitle","label":"Article Title"},{"value":"International Journal of Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijsu.2017.01.115","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 IJS Publishing Group Ltd. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}